Faeth Therapeutics, Inc.
FTH
$32.34
$3.7913.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M |
| Total Depreciation and Amortization | 25.00K | 30.00K | 34.00K | 34.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.83M | 146.15M | 533.00K | 479.00K | 478.00K |
| Change in Net Operating Assets | -3.52M | 13.32M | 286.00K | 469.00K | -1.49M |
| Cash from Operations | -15.67M | -10.73M | -3.86M | -3.59M | -5.91M |
| Capital Expenditure | 0.00 | -6.00K | 0.00 | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 210.00K |
| Cash Acquisitions | 0.00 | 6.46M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -108.07M | -37.89M | 2.08M | 1.74M | 8.56M |
| Cash from Investing | -108.07M | -31.44M | 2.08M | 1.74M | 8.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.00K | -62.00K | -113.00K | -152.00K | -314.00K |
| Issuance of Common Stock | 98.00K | 1.03M | 2.00K | 0.00 | 5.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | -1.00K | 0.00 |
| Issuance of Preferred Stock | 0.00 | 200.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.76M | -15.15M | 0.00 | 1.00K | 141.00K |
| Cash from Financing | -1.68M | 185.83M | -111.00K | -152.00K | -168.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.42M | 143.66M | -1.89M | -2.00M | 2.68M |